Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

SWITZERLAND DAYBOOK: Valeant Buys PharmaSwiss; HBM Makes Profit

Feb. 1 (Bloomberg) -- Valeant Pharmaceuticals International, Inc. will acquire privately owned PharmaSwiss SA for 350 million euros ($480 million), Valeant said in a PRNewswire statement today. HBM BioVentures AG said it will book a 41.9 million euro profit from the sale.

WHAT TO WATCH: *SNB Vice President Thomas Jordan speaks in Vienna (5:30 p.m.) *The Federal Statistics Office reports retail sales data for December (9:15 a.m. Zurich time) *Credit Suisse Group AG reports the Swiss purchasing managers’ index for January (9:30 a.m.)

EQUITIES: *Luzerner Kantonalbank Reports Full-Year Profit of 169.4 Million Swiss Francs ($180 Million) *Tornos Has Full-Year Sales of 160.1 Million Francs *Valartis Appoints Hermann, Kast and Reptsis *Partners Group Completes Investment in Saehwa *BKW FMB Acquires Allevard Hydroelectric Power Plant Group

MARKETS: *The SMI lost 0.8 percent to close at 6,479.15 *The SPI fell 0.7 percent to close at 5,814.95 *Euro -- Franc at 1.2919 at 7:26 a.m. Zurich time

To contact the reporter on this story: Paul Verschuur at

To contact the editor responsible for this story: Angela Cullen at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.